SEC Form D private-offering filing

Ovelle Bio Corp.

Name: Ovelle Bio Corp. - new SEC Form D private-offering filing, Dover, DE
Published: 2026-06-10

A new SEC Form D private-offering notice from Dover, DE, a $9,200,000 filer-stated offering target in Biotech. The source filing is one click away.

Ovelle Bio Corp. site↗ Verified via SEC Form D

Biotech developing in vitro gametogenesis technology to produce human egg cells from stem cells for fertility treatment

Filed 2026-06-10Filed to raise $9,200,000First money in 2026-06-02Raised so far $7,000,000HQ (as filed) Dover, DESector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified ovelle.bio↗Named in the filing 2 executives & directors

Open this row on the live feed →More new filings in Delaware →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.